Traditional procurement faces high costs, lack of supply chain transparency, and complex compliance processes. Drugdu AI is developing intelligent procurement solutions to make pharmaceutical B2B purchasing more efficient and smarter! What is Drugdu AI? Drugdu AI is a leading B2B pharmaceutical procurement platform that has built a global database of pharmaceutical suppliers. By leveraging AI-driven decision-making and data-powered supply chain optimization, Drugdu AI aims to enhance matching accuracy and reduce procurement risks. Drugdu AI’s Core Capabilities 1. Global B2B Pharmaceutical Trading Platform Drugdu.com has built a digital procurement ecosystem covering pharmaceuticals, medical devices, and pharmaceutical raw materials. It seamlessly connects manufacturers, suppliers, and buyers worldwide, facilitating efficient cross-border transactions. 2. Intelligent Supply Chain Solutions The platform provides end-to-end services, including precise supplier matching, real-time price transparency, international logistics optimization, and inventory management—significantly shortening procurement cycles and reducing transaction costs. 3. Integrated Compliance & Certification Support Drugdu AI integrates FDA, GMP, ...
In recent years, the application of artificial intelligence has been transforming industries at an unprecedented pace. As a leading AI-powered Q&A assistant, DeepSeek has quickly become a trusted partner for professionals in global trade. Particularly in the complex field of pharmaceutical trade, DeepSeek provides a range of practical tools to help businesses accurately target markets, enhance efficiency, and mitigate risks. As a global leader in cross-border pharma trade, Drugdu.com has explored ways to integrate DeepSeek’s capabilities with industry needs, delivering more efficient solutions to its users. Here’s how DeepSeek can empower your pharma trade business: I. Accurate Market Insights: AI as Your Detective (1) Quickly Identify Customers and Markets: Wondering which Southeast Asian country has the highest demand for raw pharmaceutical ingredients? DeepSeek uses big data analysis to provide swift, accurate answers and even generates visual reports, saving you time compared to traditional customs data checks. (2) Monitor Competitors in Real-Time: With DeepSeek, ...
In recent years, the application of artificial intelligence has been transforming industries at an unprecedented pace. As a leading AI-powered Q&A assistant, DeepSeek has quickly become a trusted partner for professionals in global trade. Particularly in the complex field of pharmaceutical trade, DeepSeek provides a range of practical tools to help businesses accurately target markets, enhance efficiency, and mitigate risks. As a global leader in cross-border pharma trade, Drugdu.com has explored ways to integrate DeepSeek’s capabilities with industry needs, delivering more efficient solutions to its users. Here’s how DeepSeek can empower your pharma trade business: Accurate Market Insights: AI as Your Detective Quickly Identify Customers and Markets Wondering which Southeast Asian country has the highest demand for raw pharmaceutical ingredients? DeepSeek uses big data analysis to provide swift, accurate answers and even generates visual reports, saving you time compared to traditional customs data checks. Monitor Competitors in Real-Time With ...
A grave neurodegenerative disease like Alzheimer’s whose cure is still unknown can now be managed with Dthera Sciences’ DTHR-ALZ, a novel digital therapy device which has been bestowed with the prestigious Breakthrough Device designation by the FDA.
MRI scans to get ten folds faster as Facebook collaborates with New York University (NYU) School of Medicine to spearhead a research project for the same using artificial intelligence (AI).
It is a very time-consuming task for the doctors to develop radiation therapy plans for patients with tumors.
New research by the University of South Australia in partnership with the University of Stuttgart, Flinders University and the Max Planck Institute for Informatics in Germany have developed hi-tech machine-learning algorithms to reveal a connection between personality and eye movements.
The opening of a new Biomedical Blockchain Research Center was announced by the Icahn School of Medicine at Mount Sinai and the Institute for Next Generation Healthcare which aims to solve healthcare and medical science issues with new technologies and data.
In the latter part of this year, a code of conduct for the use of artificial intelligence (AI) in healthcare will be introduced by the NHS, England, announced Harpreet Sood, associate CCIO at NHS England, at The King’s Fund’s Digital Health and Care Congress 2018 on 11 July.
Artificial intelligence based company Viz.ai, currently developing software for the detection of urgent stroke cases, has recently raised $21 million in venture capital to develop its portfolio.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.